RIGL241220C11000
- 3.40
- 0.000.00%
Rigel Pharmaceuticals Newsroom
How Much Upside Is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%
Rigel Pharmaceuticals Price Target Raised to $23 From $15 at Piper Sandler
Rigel Pharmaceuticals Analyst Ratings
Rigel to Present at the Jefferies London Healthcare Conference
Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $49
Citi Sees Good Things Ahead for Rigel -- Market Talk
Institutional Investors Are Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Biggest Bettors and Were Rewarded After Last Week's US$139m Market Cap Gain
Rigel Pharmaceuticals Up Over 36%, on Track for Highest Close Since May 2022 -- Data Talk
12 Health Care Stocks Moving In Friday's Intraday Session
Rigel Pharmaceuticals, Inc. (RIGL) Q3 2024 Earnings Call Transcript
Express News | Rigel Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results
Rigel Pharmaceuticals | 8-K: Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update
Rigel Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Rigel Pharmaceuticals GAAP EPS of $0.70 Beats by $0.63, Revenue of $55.3M Beats by $13.37M
Express News | Rigel Pharmaceuticals Q3 Net Income USD 12.4 Million Vs. IBES Estimate USD 910.2 Thousand
Rigel Pharmaceuticals 3Q Rev $55.3M >RIGL
Here Are the Major Earnings After the Close Today
Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition
Líder Europeo En Control De La Contaminación Ha Presentado Las Estrategias Que Guiarán Su Expansión Global
Le Leader Européen Du Contrôle De La Contamination a Présenté Les Stratégies Qui Guideront Son Expansion Mondiale Au Cours Des Cinq Prochaines Années Lors De Sa Réunion Stratégique Annuelle